MARKET

NTRB

NTRB

Nutriband Inc
NASDAQ
6.93
-0.04
-0.50%
After Hours: 7.01 +0.09 +1.23% 19:30 09/14 EDT
OPEN
6.92
PREV CLOSE
6.96
HIGH
7.04
LOW
6.52
VOLUME
108.63K
TURNOVER
--
52 WEEK HIGH
8.63
52 WEEK LOW
2.800
MARKET CAP
84.18M
P/E (TTM)
-2.6373
1D
5D
1M
3M
1Y
5Y
1D
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
Barchart · 5d ago
Nutriband receives notice of publication from USPTO
TipRanks · 6d ago
Weekly Report: what happened at NTRB last week (0831-0904)?
Weekly Report · 09/07 10:24
Nutriband Q2 EPS $(0.07) Up From $(2.12) YoY, Sales $437.514K Down From $622.452K YoY
Benzinga · 09/04 21:46
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 09/03 17:06
Weekly Report: what happened at NTRB last week (0824-0828)?
Weekly Report · 08/31 10:32
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 08/24 17:06
Weekly Report: what happened at NTRB last week (0817-0821)?
Weekly Report · 08/24 10:33
More
About NTRB
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Webull offers Nutriband Inc stock information, including NASDAQ: NTRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRB stock methods without spending real money on the virtual paper trading platform.